Table 1 General characteristics of patients in the two groups
From: COVID-19 vaccination of patients with chronic immune-mediated inflammatory disease
Demographics | IMID group (n = 158) | Control group (n = 153) | P |
|---|---|---|---|
Age (years) | 40 ± 14 | 41.3 ± 16.1 | 0.902 |
Female, n (%) | 98 (62%) | 96 (62.7%) | 0.355 |